[1] Jin YH, Cai L, Cheng ZS, et al.A Rapid Advice Guideline for the Diagnosis and Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia (Standard Version)[J].Mil Med Res, 2020, 7(1):4.
[2] Wang D, Hu B, Hu C, et al.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.[J]. JAMA, 2020, 323(11):1061-1069.
[3] 国家卫生健康委办公厅, 国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL].(2020-02-18).http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml
[4] Nishiura H, Jung SM, Linton NM, et al.The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020[J]. J Clin Med, 2020, 9(2):330.
[5] Hui DS, I Azhar E, Madani TA, et al.The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health - The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China[J].Int J Infect Dis, 2020, 91:264-266.
[6] Huang C, Wang Y, Li X, et al.Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
[7] HungIF, To KK, Lee CK, et al. Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection[J]. Clin Infect Dis, 2011, 52(4):447-456.
[8] Kraft CS, Hewlett AL, Koepsell S, et al.The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States[J].Clin Infect Dis, 2015, 61(4):496-502.
[9] Ko JH, Seok H, CHo SY, et al.Challenges of Convalesce
nt Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience[J]. Antivir Ther, 2018, 23(7):617-622.
[10] Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al.The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-Analysis[J].J Infect Dis, 2015, 211(1):80-90. |
